Apotheek Vertommen
Board
2 directors, 1 in day-to-day management, last change in 2024Director (not named in the articles)
appointed by deed of 14-01-2020
earlier director, from 01-01-2020 to 12-01-2024
listed in the 2025 annual accounts, filed on 21-08-2026
Director (not named in the articles) and managing director, permanent representative
appointed by deed of 14-01-2020
listed in the 2025 annual accounts, filed on 21-08-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Two directors jointlydeed of 12-01-2024
Permanent representatives 1
Mandates through the years
2 names, the dashed line is todayDirector (not named in the articles)
Managing director, Director (not named in the articles)
LeadershipBoardEarliermandate already running before its first mention
Mandates as a list
-
- Director, appointed by deed of 14-01-2020, until 12-01-2024
- Director (not named in the articles), since before 12-01-2024
-
- Director, appointed by deed of 14-01-2020, until 12-01-2024
- Managing director, appointed by deed of 14-01-2020, still in office
- Director (not named in the articles), since before 12-01-2024
With Starter you also see 5 former office holders in the mandate history.
See the plans →
Control
Parent
Equity €531,510
Profit €76,432 in 2025 (profit €72,661 in 2024)
Checked score
Source: accounts 31-03-2025
100%
This company
Apotheek Vertommen
Equity €407,410
Profit €20,718 in 2025
Capital
- Capital
- €214,230
- Shares
- 114,407
- Contribution per share
- €1.87
- Equity per share
- €3.56 in 2025
- Source
- deed of 12-01-2024
Owners through the years
as the annual accounts name themSource: lists of holdings in the owners' accounts
Articles of association
deed of 12-01-2024 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 3 directorsOverblijvende bestuurders mogen nieuwe bestuurder coöpteren bij openvallen voor einde mandaatTenminste helft leden aanwezig of vertegenwoordigd, meerderheid van stemmen
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Friday of June at 20:00
Capital transactions
Capital over time
- 12-01-2024 Capital stated in the deed · €214,230 · 114,407 shares
- 28-11-2014 Capital increase of €152,230 · to €214,230 · 52,407 new shares